iuvo BioScience Acquires Promedica International

Ampersand Capital Partners Invests in iuvo BioScience

September 28, 2022

Healthcare Services

Ampersand Capital Partners has agreed to acquire a stake in iuvo BioScience, a Rochester-based specialty CRO that provides laboratory, preclinical, clinical development, and scientific consulting services. The investment will fund expansion of iuvo's integrated service portfolio and laboratory capacity and support an active inorganic (add-on) growth strategy; founders Ben Burton and Mary Richardson will remain in leadership roles and as shareholders.

Canyon Labs Acquires iuvo BioScience's Lab Services and Scientific Consulting Divisions

January 7, 2025

Healthcare Services

Canyon Labs has acquired the laboratory services and scientific consulting businesses of iuvo BioScience, integrating the lab and consulting personnel into Canyon Labs' operations while iuvo retains its ophthalmic clinical research team. The deal expands Canyon Labs' testing and consulting capabilities (adding a Rochester, NY site) and allows iuvo to sharpen its focus on ophthalmic clinical trial services.

KKR and Impilo Acquire Immedica Pharma

January 24, 2025

Pharmaceuticals

KKR and Nordic healthcare investor Impilo have completed a joint acquisition of Stockholm-based Immedica Pharma, with Immedica management reinvesting alongside the new owners. Immedica is a commercial-stage pharmaceutical company focused on rare and specialty diseases (notably hematology, oncology and genetic/metabolic disorders) with ~€100m revenue and more than 120 employees; CVC Credit provided debt financing and Impilo used a single-asset continuation fund supported by secondary investors.

ARCHIMED Acquires and Merges Symbio and Proinnovera to Form Symbio Proinnovera

November 17, 2023

Healthcare Services

ARCHIMED has acquired US-based Symbio and Germany-based Proinnovera in an all-equity deal and merged them to create Symbio Proinnovera, a specialized dermatology-focused CRO. The combined group will offer end-to-end dermatology consulting, formulation, testing and clinical research across North America and Europe, with founders rolling equity into the new platform and ARCHIMED-appointed operating partners joining the board to drive growth and further acquisitions.

United BioSource (UBC) Acquires Evidinno Outcomes Research

January 5, 2026

Healthcare Services

United BioSource LLC (UBC) has acquired Vancouver-based Evidinno Outcomes Research Inc., adding real-world evidence (RWE), epidemiology, evidence synthesis and HEOR capabilities to UBC's evidence-generation platform. Evidinno will operate as a wholly owned subsidiary of UBC; Fairmount Partners served as exclusive financial advisor to Evidinno.

IK Partners Acquires Medica Group

July 7, 2023

Healthcare Services

IK Partners, via newly incorporated Moonlight Bidco Limited, has completed its acquisition of Medica Group Plc, a market-leading teleradiology and imaging-services provider headquartered in Hastings, UK. The transaction (effective 6 July 2023) takes Medica private; IK says it will support Medica's growth by investing in people, technology and new capabilities, including through M&A.